Skip to main content
David Clemmons, MD, Endocrinology, Chapel Hill, NC

David R Clemmons MD

Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology


Physician

Join to View Full Profile
  • 101 Manning DrChapel Hill, NC 27514

  • Phone+1 919-966-8596

  • Fax+1 919-843-5515

Dr. Clemmons is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. David Clemmons is an endocrinologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. He received his medical degree from University of North Carolina at Chapel Hill School of Medicine and has been in practice 43 years. He specializes in diabetes, lipid metabolism, and pituitary disorders & neuroendocrinology.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1977 - 1979
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1976 - 1977
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1974 - 1976
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1974

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1974 - 2021

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Elected Member The American Society for Clinical Investigation, 1987

Publications & Presentations

PubMed

Journal Articles

  • A Consensus Statement on Acromegaly Therapeutic Outcomes  
    David R Clemmons, Shlomo Melmed, Anne Klibanski, Nature

Lectures

  • VPI-2690B, a Novel Alphavbeta3 Integrin Antibody, Reduces Hyperglycemia-induced Changes in Renal Function in a Rat Model of Diabetic Nephropathy 
    Chapel Hill, NC - 6/14/2014

Other

Press Mentions

  • The New Gender Rules in Sports
    The New Gender Rules in SportsOctober 15th, 2019

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: